Medical Health Lab INC

Medical Health Lab INC was paid $48K by Medicaid between Jan 2018 and Dec 2024, across 52 billing codes. Its largest line is G0481, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed — 25% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#189 of 436

Median peer was paid$17K

This provider vs. median2.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	390	$0.00
2019	172	$0.00
2020	946	$683.68
2021	564	$1K
2022	186	$737.03
2024incomplete	1,678	$46K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	25%	179	167	$12K
87481		17%	124	115	$8K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	15%	198	172	$7K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	9.5%	189	175	$5K
87653		3.9%	135	124	$2K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	3.8%	132	121	$2K
87500		3.7%	131	120	$2K
87641		3.7%	131	120	$2K
87640		2.7%	132	121	$1K
87529		2.1%	59	51	$1K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.9%	59	51	$931.00
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.9%	59	51	$931.00

40 more codes

87563		1.9%	59	$931.00
87511		1.7%	59	$813.08
80061	Lipid panel	1.4%	275	$693.02
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	1.3%	59	$648.79
83036	Hemoglobin; glycosylated (A1C)	1.0%	246	$490.66
80053	Comprehensive metabolic panel	<1%	236	$320.04
80050	General health panel	<1%	14	$247.93
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	233	$233.17
84443	Thyroid stimulating hormone (TSH)	<1%	126	$183.40
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	14	$172.43
82565		<1%	86	$55.61
84436		<1%	22	$27.34
82575		<1%	57	$27.27
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	15	$24.35
36415	Collection of venous blood by venipuncture	0%	230	$0.00
80349		0%	26	$0.00
80358		0%	27	$0.00
83520		0%	42	$0.00
80368		0%	26	$0.00
80363		0%	27	$0.00
80353		0%	27	$0.00
80359		0%	27	$0.00
80357		0%	27	$0.00
80367		0%	27	$0.00
80324		0%	26	$0.00
80338		0%	27	$0.00
80372		0%	27	$0.00
80348		0%	27	$0.00
80346		0%	27	$0.00
83992		0%	21	$0.00
80336		0%	27	$0.00
80373		0%	27	$0.00
80366		0%	28	$0.00
80355		0%	26	$0.00
80356		0%	27	$0.00
80354		0%	27	$0.00
80370		0%	27	$0.00
80365		0%	27	$0.00
80360		0%	23	$0.00
80361		0%	27	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRIZVI, SYED (OWNER)

Same official

Other billing entities under RIZVI, SYED

Full network →

Provider	Location	Paid
DR. Syed S.Rizvi DDS. a Professional Corporation	Stockton, CA	$6.72M
Valley Ob/Gyn Medical Group,inc.	Hemet, CA	$5.75M
Syed M Rizvi MD LLC	Media, PA	$91K
Remedial Medical Services INC	Riverside, CA	$75K
Empower Medical Group INC	Orange, CA	$48K
Pulmonary Sleep and Critical Care Specialists of North Texas, PA	Decatur, TX	$24K
S M Hammad Rizvi M D INC	Upland, CA	$18K
Southern Healthcare Services LLC	Houston, TX	$6K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.